Search results
Results from the WOW.Com Content Network
The term "backdoor pathway" was coined by Auchus in 2004 [25] and was described as 5α-reduction of 17α-hydroxyprogesterone (17OHP) which is a first step in a pathway that ultimately leads to the production of dihydrotestosterone (DHT). and defined as a route to DHT that: (1) bypasses conventional intermediates androstenedione (A4) and T; (2 ...
As with the conventional pathway of DHT synthesis, the backdoor pathway similarly requires 5α-reductase. [63] Whereas 5α-reduction is the last transformation in the classical androgen pathway, it is the first step in the backdoor pathway. [17]
The androgen backdoor pathway (red arrows) roundabout testosterone embedded in within conventional androgen synthesis that lead to 5α-dihydrotestosterone through testosterone. [7] [8] [9] 5α-Pregnan-17α-ol-3,20-dione (17-OH-DHP) is a progestogen, i.e., it binds to the progesterone receptors.
Cholesterol side-chain cleavage enzyme (20,22-desmolase) – steroid synthesis; 17,20-Lyase (17,20-desmolase) – androgen synthesis; Steroid hydroxylases. 11β-Hydroxylase – corticosteroid synthesis; 17α-Hydroxylase – androgen and glucocorticoid synthesis; 18-Hydroxylase (aldosterone synthase) – mineralocorticoid synthesis
Also involved into a backdoor pathway from 17α-hydroxyprogesterone to dihydrotestosterone by 3α-reduction of a metabolic intermediary, 17α-hydroxydihydroprogesterone, into another intermediary, 17α-hydroxyallopregnanolone. [21] May be involved in the pathophysiology of PCOS Tooltip polycystic ovary syndrome. [12]
The androgen backdoor pathway (red arrows) roundabout testosterone embedded in within conventional androgen synthesis that lead to 5α-dihydrotestosterone through testosterone [27] [28] [29] CAH is a genetic disorder characterized by impaired production of cortisol in the adrenal glands. [1] [4] Production of cortisol begins at week 8 of fetal ...
Dihydrotestosterone increased the number of BrdU cells, while flutamide inhibited these cells. Moreover, estrogens had no effect. This research demonstrates how androgens can increase AHN. [19] Researchers also examined how mild exercise affected androgen synthesis which in turn causes AHN activation of N-methyl-D-aspartate (NMDA) receptors.
5α-Reductase inhibitors (5-ARIs), also known as dihydrotestosterone (DHT) blockers, are a class of medications with antiandrogenic effects which are used primarily in the treatment of enlarged prostate and scalp hair loss. They are also sometimes used to treat excess hair growth in women and as a component of hormone therapy for transgender ...